Regeneron Announces Presentation and Panel Discussion at the 33rd Annual J.P. Morgan Healthcare Conference

TARRYTOWN, N.Y.,Dec. 19, 2014/PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) will webcast management presentations at the 33rdAnnual J.P. Morgan Healthcare Conference as follows:

• Panel discussion "Harnessing the Power of Next Gen Sequencing - The View From Industry" onMonday, January 12, 2015at5:00 p.m. Pacific Time(8:00 p.m. Eastern Time)

• Company presentation onTuesday, January 13, 2015at10:30 a.m. Pacific Time(1:30 p.m. Eastern Time)

Both webcasts may be accessed through the Company's web site,www.regeneron.com, on the 'Events and Presentations' page.  Archived versions of the presentations will be available for 30 days.

About Regeneron Pharmaceuticals, Inc.Regeneron is a leading science-based biopharmaceutical company based inTarrytown, New Yorkthat discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.  Regeneron commercializes medicines for eye diseases, colorectal cancer, and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including hypercholesterolemia, oncology, rheumatoid arthritis, asthma, and atopic dermatitis.  Several Regeneron programs are based on human genetic findings.  For additional information about the company, please visitwww.regeneron.com.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/regeneron-announces-presentation-at-the-33rd-annual-jp-morgan-healthcare-conference-300010337.html